Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy

ConditionRenal Neoplasm

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-65

SponsorNational Cancer Institute, Egypt

About this trial

Aim of the study:

The current study aims to compare the effect of adding dexamethasone versus magnesium sulfate to bupivacaine in ultrasound-guided erector spinae plane block on the severity of postoperative pain.

Primary Objectives:

\- To compare the effect of ESPB without additives to the effect of adding dexamethasone and to the impact of adding magnesium sulfate in the form of post-operative morphine consumption

Eligibility criteria

Qualifiers

Adult (18 - 65)

Patients undergoing unilateral nephrectomy

ASA II / III

Disqualifiers

Patient refusal

Age less than 18 years

Allergy to any of the studied medications

Mid line incision

Trial design

Treatments tested in this trial

ultrasound guided Erector Spinae Plane Block using 27ml bupivacaine 0.25%

Treatment groups

78 Participants

are divided into 3 treatment groups

Sponsors and collaborators

National Cancer Institute, Egypt

Lead sponsor

Source ClinicalTrials.gov